CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations (Q33193071)

From Wikidata
Jump to navigation Jump to search
scientific article published on September 1, 2003
edit
Language Label Description Also known as
English
CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations
scientific article published on September 1, 2003

    Statements

    CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit